Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s):  92

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Page 1

Download in electronic PDF format for $75

Abstract:  

Related Keywords: Loyd V. Allen Jr., PhD, RPh, DQSA, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Health, Examining Implementation of the Compounding Quality Act, U.S. Food and Drug Administration, FDA, pharmacy compounding oversight and regulation, office-use compounding, Pharmacy Compounding Advisory Committee, PCAC, dietary supplements, CGMP standards, Guidance for Industry documents, HR2871

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
Mar/Apr 2018
Pg. 92

IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing
Blankenship Cynthia
Mar/Apr 2018
Pg. 125-126

Standing Together Fixing the Drug Quality and Security Act
Miller David G
Mar/Apr 2015
Pg. 104-106

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
Nov/Dec 2015
Pg. 453-463

U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
Jan/Feb 2014
Pg. 35-36

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
Jul/Aug 2017
Pg. 290-291

PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
May/Jun 2014
Pg. 180

PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Allen Loyd V Jr
Jul/Aug 2007
Pg. 350-351

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
Nov/Dec 2012
Pg. 446-450

Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
Nov/Dec 2007
Pg. 487-490

Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding
Kupiec Thomas C
, Okeke Claudia, Allen Loyd V Jr, Denison Clay
Jul/Aug 2005
Pg. 300-302

Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
Jan/Feb 2008
Pg. 63

PreScription: 2014 in Review
Allen Loyd V Jr
Jan/Feb 2015
Pg. 4

The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
Mar/Apr 2017
Pg. 116-117

Return to Top